
James Dowling MD
Neuromuscular Medicine, Child Neurology
Assistant Professor, Pediatrics & Communicable Diseases, University of
Join to View Full Profile
3400 Spruce StFl 2Philadelphia, PA 19104
Phone+1 215-662-3606
Fax+1 215-349-5579
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Dowling, MD is a board certified neurologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and Michigan. He is an Assistant Professor at University of.
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Child Neurology, 2002 - 2005
- University of ChicagoInternship, Transitional Year, 2001 - 2002
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2001
Certifications & Licensure
- PA State Medical License 2025 - 2026
- MI State Medical License 2005 - 2015
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- 7 citationsAAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient.James J Dowling, Terry Pirovolakis, Keshini Devakandan, Ana Stosic, Mia Pidsadny
Nature Medicine. 2024-07-01 - 8 citationsTrio RNA sequencing in a cohort of medically complex children.Ashish R Deshwar, Kyoko E Yuki, Huayun Hou, Yijing Liang, Tayyaba Khan
American Journal of Human Genetics. 2023-05-04 - 1 citationsCRISPR editing as a therapeutic strategy for Duchenne muscular dystrophy-anti-Cas9 immune response casts its shadow over safety and efficacy.James J Dowling
Gene Therapy. 2022-11-01
Press Mentions
- New Insights into Duchenne Muscular Dystrophy Gene Therapy: Evidence in Focus from AANMay 14th, 2025
- Duchenne Muscular Dystrophy Gene TherapyMay 14th, 2025